Jul 8, 2025 8:00am EDT Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis
May 14, 2025 9:00am EDT Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
